186 related articles for article (PubMed ID: 21529097)
1. Monte Carlo modeling of in vivo protoporphyrin IX fluorescence and singlet oxygen production during photodynamic therapy for patients presenting with superficial basal cell carcinomas.
Valentine RM; Brown CT; Moseley H; Ibbotson S; Wood K
J Biomed Opt; 2011 Apr; 16(4):048002. PubMed ID: 21529097
[TBL] [Abstract][Full Text] [Related]
2. Simulation of fractionated and continuous irradiation in photodynamic therapy: study the differences between photobleaching and singlet oxygen dose deposition.
Naghavi N; Miranbaygi MH; Sazgarnia A
Australas Phys Eng Sci Med; 2011 Jun; 34(2):203-11. PubMed ID: 21448718
[TBL] [Abstract][Full Text] [Related]
3. A dynamic model for ALA-PDT of skin: simulation of temporal and spatial distributions of ground-state oxygen, photosensitizer and singlet oxygen.
Liu B; Farrell TJ; Patterson MS
Phys Med Biol; 2010 Oct; 55(19):5913-32. PubMed ID: 20844331
[TBL] [Abstract][Full Text] [Related]
4. Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA-PDT.
Wang KK; Cottrell WJ; Mitra S; Oseroff AR; Foster TH
Lasers Surg Med; 2009 Nov; 41(9):686-96. PubMed ID: 19802891
[TBL] [Abstract][Full Text] [Related]
5. Microscopic distribution of protoporphyrin (PpIX) fluorescence in superficial basal cell carcinoma during light-fractionated aminolaevulinic acid photodynamic therapy.
de Haas ER; de Bruijn HS; Sterenborg HJ; Neumann HA; Robinson DJ
Acta Derm Venereol; 2008; 88(6):547-54. PubMed ID: 19002337
[TBL] [Abstract][Full Text] [Related]
6. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas.
Cottrell WJ; Paquette AD; Keymel KR; Foster TH; Oseroff AR
Clin Cancer Res; 2008 Jul; 14(14):4475-83. PubMed ID: 18628462
[TBL] [Abstract][Full Text] [Related]
7. Kinetic fluorescence studies of 5-aminolaevulinic acid-induced protoporphyrin IX accumulation in basal cell carcinomas.
af Klinteberg C; Enejder AM; Wang I; Andersson-Engels S; Svanberg S; Svanberg K
J Photochem Photobiol B; 1999 Apr; 49(2-3):120-8. PubMed ID: 10392462
[TBL] [Abstract][Full Text] [Related]
8. Protoporphyrin IX fluorescence induced in basal cell carcinoma by oral delta-aminolevulinic acid.
Tope WD; Ross EV; Kollias N; Martin A; Gillies R; Anderson RR
Photochem Photobiol; 1998 Feb; 67(2):249-55. PubMed ID: 9487802
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the administrated light dose during 5-ALA-mediated photodynamic therapy: Murine 4T1 breast cancer model.
Amiri H; Mokhtari-Dizaji M; Mozdarani H
Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12925. PubMed ID: 37968826
[TBL] [Abstract][Full Text] [Related]
10. The effect of an iron chelating agent on protoporphyrin IX levels and phototoxicity in topical 5-aminolaevulinic acid photodynamic therapy.
Choudry K; Brooke RC; Farrar W; Rhodes LE
Br J Dermatol; 2003 Jul; 149(1):124-30. PubMed ID: 12890205
[TBL] [Abstract][Full Text] [Related]
11. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment.
Martin A; Tope WD; Grevelink JM; Starr JC; Fewkes JL; Flotte TJ; Deutsch TF; Anderson RR
Arch Dermatol Res; 1995; 287(7):665-74. PubMed ID: 8534131
[TBL] [Abstract][Full Text] [Related]
12. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome.
Tyrrell JS; Campbell SM; Curnow A
Lasers Surg Med; 2010 Sep; 42(7):613-9. PubMed ID: 20806386
[TBL] [Abstract][Full Text] [Related]
13. Modeling PpIX effective light fluence at depths into the skin for PDT dose comparison.
LaRochelle EPM; Marra K; LeBlanc RE; Chapman MS; Maytin EV; Pogue BW
Photodiagnosis Photodyn Ther; 2019 Mar; 25():425-435. PubMed ID: 30685548
[TBL] [Abstract][Full Text] [Related]
14. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin.
Kulyk O; Ibbotson SH; Moseley H; Valentine RM; Samuel ID
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):630-9. PubMed ID: 26467274
[TBL] [Abstract][Full Text] [Related]
15. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification.
Tyrrell J; Campbell SM; Curnow A
Photodiagnosis Photodyn Ther; 2011 Mar; 8(1):30-8. PubMed ID: 21333932
[TBL] [Abstract][Full Text] [Related]
16. A quantitative study of in vivo protoporphyrin IX fluorescence build up during occlusive treatment phases.
Campbell CL; Brown CTA; Wood K; Salvio AG; Inada NM; Bagnato VS; Moseley H
Photodiagnosis Photodyn Ther; 2017 Jun; 18():204-207. PubMed ID: 28257944
[TBL] [Abstract][Full Text] [Related]
17. Imaging of hypoxia, oxygen consumption and recovery in vivo during ALA-photodynamic therapy using delayed fluorescence of Protoporphyrin IX.
Scholz M; Petusseau AF; Gunn JR; Shane Chapman M; Pogue BW
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101790. PubMed ID: 32344195
[TBL] [Abstract][Full Text] [Related]
18. Protoporphyrin IX fluorescence and photobleaching during interstitial photodynamic therapy of malignant gliomas for early treatment prognosis.
Johansson A; Faber F; Kniebühler G; Stepp H; Sroka R; Egensperger R; Beyer W; Kreth FW
Lasers Surg Med; 2013 Apr; 45(4):225-34. PubMed ID: 23533060
[TBL] [Abstract][Full Text] [Related]
19. Protoporphyrin IX formation and photobleaching in different layers of normal human skin: methyl- and hexylaminolevulinate and different light sources.
Togsverd-Bo K; Idorn LW; Philipsen PA; Wulf HC; Hædersdal M
Exp Dermatol; 2012 Oct; 21(10):745-50. PubMed ID: 22882358
[TBL] [Abstract][Full Text] [Related]
20. Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin.
de Bruijn HS; Brooks S; van der Ploeg-van den Heuvel A; Ten Hagen TL; de Haas ER; Robinson DJ
PLoS One; 2016; 11(2):e0148850. PubMed ID: 26872051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
